A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.
about
Targeting the Nrf2 Signaling Pathway in the Retina With a Gene-Delivered Secretable and Cell-Penetrating PeptideSpatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury.Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathyThe role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy.
P2860
A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A hypoxia-responsive glial cel ...... ng retinal neovascularization.
@en
type
label
A hypoxia-responsive glial cel ...... ng retinal neovascularization.
@en
prefLabel
A hypoxia-responsive glial cel ...... ng retinal neovascularization.
@en
P2093
P2860
P356
P1476
A hypoxia-responsive glial cel ...... ng retinal neovascularization.
@en
P2093
C Kathleen Dorey
Howard M Prentice
Janet C Blanks
Manas R Biswal
P2860
P304
P356
10.1167/IOVS.14-13932
P407
P577
2014-11-06T00:00:00Z